Literature DB >> 32855222

Ivacaftor modifies cystic fibrosis neutrophil phenotype in subjects with R117H residual function CFTR mutations.

Gareth R Hardisty1, Sheonagh M Law1, Suzanne Carter2, Brenda Grogan2, Pradeep K Singh3, Edward F McKone2, Robert D Gray4.   

Abstract

Entities:  

Year:  2021        PMID： 32855222      PMCID： PMC7817919          DOI： 10.1183/13993003.02161-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  14 in total

1.  Sputum proteomics in inflammatory and suppurative respiratory diseases.

Authors:  Robert D Gray; Gordon MacGregor; Donald Noble; Margaret Imrie; Maria Dewar; A Christopher Boyd; J Alastair Innes; David J Porteous; Andrew P Greening
Journal:  Am J Respir Crit Care Med       Date:  2008-06-19       Impact factor: 21.405

2.  Evaluation of red blood cell lysing solutions in the study of neutrophil oxidative burst by the DCFH assay.

Authors:  J Vuorte; S E Jansson; H Repo
Journal:  Cytometry       Date:  2001-04-01

3.  Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial.

Authors:  Richard B Moss; Patrick A Flume; J Stuart Elborn; Jon Cooke; Steven M Rowe; Susanna A McColley; Ronald C Rubenstein; Mark Higgins
Journal:  Lancet Respir Med       Date:  2015-06-09       Impact factor: 30.700

4.  Alterations in blood leukocytes of G551D-bearing cystic fibrosis patients undergoing treatment with ivacaftor.

Authors:  Preston E Bratcher; Steven M Rowe; Ginger Reeves; Tambra Roberts; Tomasz Szul; William T Harris; Rabindra Tirouvanziam; Amit Gaggar
Journal:  J Cyst Fibros       Date:  2015-03-11       Impact factor: 5.482

5.  A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy.

Authors:  Kerstin Pohl; Elaine Hayes; Joanne Keenan; Michael Henry; Paula Meleady; Kevin Molloy; Bakr Jundi; David A Bergin; Cormac McCarthy; Oliver J McElvaney; Michelle M White; Martin Clynes; Emer P Reeves; Noel G McElvaney
Journal:  Blood       Date:  2014-06-16       Impact factor: 22.113

Review 6.  Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2.

Authors:  Hyun Lee; Peter L Whitfeld; Charles R Mackay
Journal:  Immunol Cell Biol       Date:  2008-01-29       Impact factor: 5.126

7.  Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutation.

Authors:  Jeffrey S Wagener; Stefanie J Millar; Nicole Mayer-Hamblett; Gregory S Sawicki; Edward F McKone; Christopher H Goss; Michael W Konstan; Wayne J Morgan; David J Pasta; Richard B Moss
Journal:  J Cyst Fibros       Date:  2017-10-31       Impact factor: 5.482

Review 8.  Origins of cystic fibrosis lung disease.

Authors:  David A Stoltz; David K Meyerholz; Michael J Welsh
Journal:  N Engl J Med       Date:  2015-01-22       Impact factor: 91.245

9.  A Comparison of Human Neutrophils Acquired from Four Experimental Models of Inflammation.

Authors:  Alexander A Maini; Marc J George; Madhur P Motwani; Richard M Day; Derek W Gilroy; Alastair J O'Brien
Journal:  PLoS One       Date:  2016-10-25       Impact factor: 3.240

10.  The Application of Dextran Sedimentation as an Initial Step in Neutrophil Purification Promotes Their Stimulation, due to the Presence of Monocytes.

Authors:  Alex Quach; Antonio Ferrante
Journal:  J Immunol Res       Date:  2017-10-15       Impact factor: 4.818
View more
  5 in total

Review 1.  Mucosal Immunity in Cystic Fibrosis.

Authors:  Christine M Bojanowski; Shiping Lu; Jay K Kolls
Journal:  J Immunol       Date:  2021-12-15       Impact factor: 5.426

Review 2.  Our evolving view of neutrophils in defining the pathology of chronic lung disease.

Authors:  Kyle T Mincham; Nicoletta Bruno; Aran Singanayagam; Robert J Snelgrove
Journal:  Immunology       Date:  2021-10-04       Impact factor: 7.215

Review 3.  The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis.

Authors:  Caitlyn Harvey; Sinead Weldon; Stuart Elborn; Damian G Downey; Clifford Taggart
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

Review 4.  CF Fungal Disease in the Age of CFTR Modulators.

Authors:  Amelia Bercusson; George Jarvis; Anand Shah
Journal:  Mycopathologia       Date:  2021-04-04       Impact factor: 2.574

Review 5.  Revisiting the Role of Leukocytes in Cystic Fibrosis.

Authors:  Monica Averna; Paola Melotti; Claudio Sorio
Journal:  Cells       Date:  2021-12-01       Impact factor: 6.600
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.